The differences in homocysteine level between obstructive sleep apnea patients and controls: A meta-analysis

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Niu, Xun ^a   Chen, Xiong ^a   Xiao, Ying ^a   Dong, Jiaqi ^a   Zhang, Rui ^a   Lu, Meixia ^a   Kong, Weijia ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

AGE; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINA; CONTROLLED STUDY; HUMAN; PATIENT ASSESSMENT; SLEEP DISORDERED BREATHING; UPREGULATION; BLOOD; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; COMPLICATION; META ANALYSIS;

CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; HOMOCYSTEINE; HUMANS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84899713524     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095794     Document Type: Article

References (38)

1. Ryan CM, Bradley TD (2005) Pathogenesis of obstructive sleep apnea. J Appl Physiol (1985) 99:2440-50
2. Xiao Y, Chen X, Shi H, Yang Y, He L, et al. (2011) Evaluation of airway obstruction at soft palate level in male patients with obstructive sleep apnea/hypopnea syndrome: dynamic 3-dimensional CT imaging of upper airway. J Huazhong Univ Sci Technolog Med Sci 31:413-8
3. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, et al. (2013) Increased Prevalence of Sleep-Disordered Breathing in Adults. Am J Epidemiol
4. Martinez D, Klein C, Rahmeier L, da Silva RP, Fiori CZ, et al. (2012) Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors. Sleep Breath 16:695-701
5. Macey PM, Kumar R, Woo MA, Yan-Go FL, Harper RM (2013) Heart rate responses to autonomic challenges in obstructive sleep apnea. PLoS One 8:e76631
6. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, et al. (2004) Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Z Kardiol 93:439-53 (Pubitemid 38858323)
7. Ford AH, Garrido GJ, Beer C, Lautenschlager NT, Arnolda L, et al. (2012) Homocysteine, grey matter and cognitive function in adults with cardiovascular disease. PLoS One 7:e33345
8. Zhou YH, Tang JY, Wu MJ, Lu J, Wei X, et al. (2011) Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis. PLoS One 6:e25142
9. Girelli D, Martinelli N, Olivieri O, Pizzolo F, Friso S, et al. (2006) Hyperhomocysteinemia and mortality after coronary artery bypass grafting. PLoS One 1:e83
10. Mangoni AA, Jackson SH (2002) Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med 112:556-65 (Pubitemid 34518316)
11. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-48
12. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-58 (Pubitemid 34746062)
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-60 (Pubitemid 37088507)
14. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-88 (Pubitemid 17189972)
15. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-34 (Pubitemid 27387172)
16. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-101
17. Duval S, Tweedie R (2000) Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455-63 (Pubitemid 30422636)
18. Lavie L, Perelman A, Lavie P (2001) Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity. Chest 120:900-8 (Pubitemid 32885467)
19. Kokturk O, Ciftci TU, Mollarecep E, Ciftci B (2006) Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome. Respir Med 100:536-41 (Pubitemid 43239888)
20. Ozkan Y, Firat H, Simsek B, Torun M, Yardim-Akaydin S (2008) Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath 12:149-54 (Pubitemid 351486675)
21. Wang X, Yao FM (2008) Plasma homocysteic acid in patients with obstructive sleep apnea syndrome. Chin J Hypertension 16:253-6
22. Wang L, Li J, Xie Y, Zhang XG (2010) Association between serum homocysteine and oxidative stress in elderly patients with obstructive sleep apnea/hypopnea syndrome. Biomed Environ Sci 23:42-7
23. Cintra F, Tufik S, D'Almeida V, Calegare BF, de Paola A, et al. (2011) Cysteine: a potential biomarker for obstructive sleep apnea. Chest 139:246-52
24. Chen M, Wu B, Ye X, Zhou Z, Yue X, et al. (2011) Association between plasma homocysteine levels and obstructive sleep apnoea in patients with ischaemic stroke. J Clin Neurosci 18:1454-7
25. Basoglu OK, Sarac F, Sarac S, Uluer H, Yilmaz C (2011) Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med 6:120-5
26. Monneret D, Tamisier R, Ducros V, Garrel C, Levy P, et al. (2012) The impact of obstructive sleep apnea on homocysteine and carotid remodeling in metabolic syndrome. Respir Physiol Neurobiol 180:298-304
27. Sales LV, Bruin VM, D'Almeida V, Pompeia S, Bueno OF, et al. (2013) Cognition and biomarkers of oxidative stress in obstructive sleep apnea. Clinics (Sao Paulo) 68:449-55
28. Petrisor BA, Keating J, Schemitsch E (2006) Grading the evidence: levels of evidence and grades of recommendation. Injury 37:321-7 (Pubitemid 43363516)
29. Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, et al. (2007) Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62:509-14 (Pubitemid 46910129)
30. Svatikova A, Wolk R, Magera MJ, Shamsuzzaman AS, Phillips BG, et al. (2004) Plasma homocysteine in obstructive sleep apnoea. Eur Heart J 25:1325-9 (Pubitemid 38998509)
31. Geisel J, Hennen B, Hubner U, Knapp JP, Herrmann W (2003) The impact of hyperhomocysteinemia as a cardiovascular risk factor in the prediction of coronary heart disease. Clin Chem Lab Med 41:1513-7 (Pubitemid 37493569)
32. Wood D (2001) Established and emerging cardiovascular risk factors. Am Heart J 141:S49-57
33. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049-57
34. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S (1999) Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 131:363-75 (Pubitemid 29424631)
35. Silvestrini M, Rizzato B, Placidi F, Baruffaldi R, Bianconi A, et al. (2002) Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 33:1782-5 (Pubitemid 34761060)
36. McNicholas WT, Bonsigore MR (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29:156-78 (Pubitemid 46092013)
37. Labuz-Roszak B, Tazbirek M, Pierzchala K, Pierzchala W (2004) [Frequency of sleep apnea syndrome in patients with acute stroke]. Pol Merkur Lekarski 16:536-8
38. Brown DL (2006) Sleep disorders and stroke. Semin Neurol 26:117-22